|Bid||14.35 x 800|
|Ask||20.05 x 800|
|Day's Range||18.75 - 19.07|
|52 Week Range||14.40 - 20.45|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 11, 2017 - May 12, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.80|
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Jason Shandell, President, and Bill Peters, CFO will be presenting at the Wells Fargo Healthcare Conference on Thursday, September 6, 2018 at 9:10 a.m. Eastern Time in Boston, MA. This presentation will be made available with a live webcast and may be accessed by visiting Amphastar’s Pharmaceuticals website at http://ir.amphastar.com. Amphastar is a specialty pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products.
NEW YORK, Aug. 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Rapid7, ...
Amphastar (AMPH) delivered earnings and revenue surprises of -62.50% and 10.87%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Rancho Cucamonga, California-based company said it had a loss of 6 cents. Earnings, adjusted for one-time gains and costs, were 3 cents per share. The results did not meet Wall ...
Reports Net Revenues of $71.0 Million for the Three Months Ended June 30, 2018. RANCHO CUCAMONGA, Calif., Aug. 08, 2018-- Amphastar Pharmaceuticals, Inc. today reported results for the three months ended ...
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Amphastar Pharmaceuticals Inc (NASDAQ: AMPH ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 5:00 PM Eastern ...
Amphastar Pharmaceuticals, Inc. (AMPH) announced that the Company will release results for its second quarter of 2018 ended June 30, 2018, after the market closes on Wednesday, August 8, 2018, and will hold a conference call to discuss its financial results at 2:00 p.m. Pacific Time. To access the conference call, dial toll free (877) 881-2595, or (315) 625-3083 for international callers, five minutes before the conference. The passcode for the conference call is 8783989.
Amphastar Pharmaceuticals, Inc. (AMPH) announced business expansion plans for its subsidiary, Amphastar Nanjing Pharmaceuticals Inc. (“ANP”). To date, ANP has provided Active Pharmaceutical Ingredients (“APIs”) and starting materials specifically to Amphastar. After the expansion is completed, ANP intends to begin selling APIs both to Amphastar and externally around the world to expand its overall markets.
Measuring Amphastar Pharmaceuticals Inc’s (NASDAQ:AMPH) track record of past performance is a valuable exercise for investors. It allows us to understand whether or not the company has met or exceedRead More...
Amphastar (AMPH) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.
If you are a shareholder in Amphastar Pharmaceuticals Inc’s (NASDAQ:AMPH), or are thinking about investing in the company, knowing how it contributes to the risk and reward profile of yourRead More...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on May 14) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. (NYSE: ...